NCT03099356 2025-08-01Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid CancerUniversity of Michigan Rogel Cancer CenterPhase 2 Recruiting22 enrolled